Randomized trials comparing Telmisartan vs. Valsartan and Losartan 24-hour ambulatory blood pressure control, GLP-1 heart failure outcomes, UKPDS 34 cardiovascular mortality reductions, and statin + ezetimibe ApoB targets. Explore 714 indexed studies and multi-trial syntheses with verified PubMed PMIDs, participant sample sizes (N), and Absolute vs. Relative Risk numbers.
The Plain-English Receipt: Only 1.2% of prediabetic adults on Tirzepatide progressed to Type 2 diabetes over 3.4 years vs. 19.3% on placebo (Absolute Risk Reduction = 18.1% • Number Needed to Treat = 6).
Simulated furosemide exposure was consistent with published values, supporting an 80-mg dose of subcutaneous furosemide (30 mg over the first hour, then 12.5 mg/h for 4 h) for adolescents aged 12-17 years with body weight ≥...
Sleep, a modifiable behavior, may be a secondary prevention target to reduce the risk of recurrent event and death following stroke.
Addition of ezetimibe to a moderate weight loss diet in obese subjects can significantly improve liver steatosis, inflammation, and LDL-apoB-100 metabolism.
Metabolic parameters, liver function, and kidney function did not change significantly.
These results suggest that both AML and LOS are equally effective in lowering daytime blood pressure without eliciting reflex fast heart rate, however, the blood-pressure-lowering effect of AML lasts longer than that of LOS.
In CAD patients, the combination treatment with statins and exercise resulted in significant amelioration of arterial wall stiffness, at least in part, through reduction of circulating basophils.
These findings suggest that calcium channel blocker amlodipine inhibits ROCK activity in patients with high blood pressure.
Continued clinical improvement during prolonged rilonacept treatment corresponded with improvement on CMR, including reduced pericardial thickness, resolution of pericardial oedema, and resolution of LGE.
Despite the general conception, moderate-intensity statins are not adequate for the majority of patients with T2DM and mild high cholesterol and greater numbers of patients could reach the LDL cholesterol target with...
Among rosuvastatin patients (n = 156), there was no difference in dose needed to reach target LDL-C, measured LDL-C, or lathosterol concentrations, when administered in a fed or fasting state.
ER niacin reduces apoB-48 concentration by lowering fasting and postprandial apoB-48 secretion rate.
The FDC formulations demonstrated similar bioavailability to coadministered commercially available amlodipine and rosuvastatin.
Plasma ceramides and sphingomyelin were not associated with the kinetics or concentrations of high-density lipoprotein apoA-I, and low-density lipoprotein apoB.
In this study, Japanese adults with EHT had significant increases in adiponectin after 3 months of treatment with 50 to 100 mg/d of losartan, but not with 5 to 10 mg/d of amlodipine.
Getting both at the same time of ezetimibe 10 mg with rosuvastatin 10 mg daily caused a significant incremental reduction in LDL-C compared with rosuvastatin alone.
In 2000, Professor Jemilah Mahmood watched television images of devastating floods in Mozambique as a helicopter rescued a woman giving birth in a tree. As an obstetrician and gynaecologist, the image stayed with her for nearly two decades. In 2019, while visi
Consuming several servings of whole grains each day may lower certain risk factors for cardiovascular disease, according to a systematic review and meta-analysis published in the European Heart Journal.
Many men are failing to thrive. Shorter life expectancies for men than for woman first emerged in the 19th century and the gap has continued to widen (albeit with geographical variations). Men have a higher burden of illness: global disability-adjusted life-ye
Emergency department overcrowding and access block are now among the most consequential patient-safety problems facing acute hospitals globally.1 The associated harm is measurable, dose-dependent, and has no clearly safe threshold beyond approximately 5 h.2 Pa
Reason for Recall (Class III): Superpotent Drug: potential for the Telmisartan content in these lots to exceed specifications
“Do I need to treat this blood pressure?” is one of the most common questions to pass through the minds of acute care pediatricians during a typical day in the hospital. Blood pressure generally increases with somatic growth, reflecting developmental changes i
This randomized clinical trial examines whether adopting a permissive mean arterial blood pressure target improves outcomes in critically ill children with hypotension.
To investigate the relationship between obesity, body mass index (BMI) rebound, body composition changes, associated factors (e.g., diet, physical activity), and cardiovascular risk factor status in a longitudinal study of young children, a
Low molecular weight heparin is a drug with anticoagulant and antithrombotic effects. This drug is frequently administered subcutaneously to patients by nurses. Complications such as pain, ecchymosis and hematoma may commonly occur at the i
Traditional health headlines often exaggerate findings by reporting only Relative Risk Reduction—for example, claiming a drug cuts risk by 50% when the event rate dropped from 2% to 1% (an Absolute Risk Reduction of just 1.0 percentage point, meaning 100 patients must take the drug for 1 person to benefit, or NNT = 100). On dotMD, every flagship study breakdown reports both Relative Risk and Absolute Risk alongside the exact sample size (N) and trial duration.
Every study on dotMD displays its exact Study Design Tier at the top of the card (Phase 3 Randomized Trial, Randomized Controlled Trial, Meta-Analysis & Systematic Review, Multi-Trial Clinical Evidence Synthesis, Journal Watch Cohort, or FDA Safety Alert) along with the human participant count (N). Preclinical mouse or cell-culture data is never presented as human clinical proof.
Arbitrary 0-to-100 rigor scores obscure what actually makes a study trustworthy. Instead of synthetic scores, dotMD surfaces the verifiable primary evidence signals: exact NCBI PubMed IDs (PMID), ClinicalTrials.gov registration numbers (NCT), double-blind vs. crossover design, sample size (N), p-values / Hazard Ratios, and study limitations.
Medical research is only useful if you can act on it safely with your clinician. Every flagship research synthesis links directly to the parent Condition diagnostic cutoff guide, the Medication FDA DailyMed & CMS NADAC wholesale price ledger, the Supplement elemental weight decoder, and our High-CPT-Volume Specialist Directory.
